ERBB2 and breast cancer: We analysed the most efficient compounds for their ability to induce LMP, autophagy, cathepsin B inhibition and to inhibit invasion of lapatinib-resistant HER2 positive mammary cancer spheroids and HER2 positive, lapatinib-resistant ovarian cancer organoids using high-throughput confocal microscopy and digital image analysis.